
Chemical and Pharmaceutical Bulletin p. 1130 - 1134 (1998)
Update date:2022-08-03
Topics:
Baba, Atsuo
Makino, Haruhiko
Ohta, Yoshikazu
Sohda, Takashi
The metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (1, TAK-603), which is under clinical evaluation as a new type of disease-modifying antirheumatic drug (DMARD), were prepared to confirm th
View MoreContact:+86-134-5286-9121
Address:Add: Wing Tuck Commercial Centre, 177-183 Wing Lok Street, Hong Kong,
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
KA-SHING Business Trade Macau Co., Ltd.
Contact:00853-28430045
Address:23rd Floor, Block 3 La Cite, Areia Preta, Macao
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
Doi:10.1039/c6cc05707a
(2016)Doi:10.1039/a802797h
(1998)Doi:10.1039/a801922c
(1998)Doi:10.1021/jo01046a525
(1963)Doi:10.1016/j.jfluchem.2005.03.020
(2005)Doi:10.1055/s-2006-950244
(2006)